Christopher Charles Schreiber's most recent trade in TNF Pharmaceuticals Inc. was a trade of 150,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 7, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TNF Pharmaceuticals Inc. | Christopher Charles Schreiber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) |